buformin has been researched along with Cancer of Kidney in 3 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isono, T | 2 |
| Chano, T | 2 |
| Kitamura, A | 1 |
| Yuasa, T | 2 |
| Yonese, J | 1 |
| Alexandrov, VA | 1 |
| Anisimov, VN | 1 |
| Belous, NM | 1 |
| Vasilyeva, IA | 1 |
| Mazon, VB | 1 |
3 other studies available for buformin and Cancer of Kidney
| Article | Year |
|---|---|
Glucose deprivation induces G2/M transition-arrest and cell death in N-GlcNAc2-modified protein-producing renal carcinoma cells.
Topics: Acetylglucosamine; Activating Transcription Factor 3; Buformin; Cell Death; Cell Line, Tumor; G2 Pha | 2014 |
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas.
Topics: Acids; Buformin; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Epoxy Compounds; Flow Cytometr | 2016 |
The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats.
Topics: Animals; Buformin; Cholesterol; Dietary Carbohydrates; Diethylstilbestrol; Energy Metabolism; Female | 1980 |